01 February 2006
The influence of different treatment modalities on clinical improvement and reduction of cyclosporine A-induced gingival overgrowth
Małgorzata Radwan- Oczko, Maria BoratyńskaCase Rep Clin Pract Rev 2006; 7:58-63 :: ID: 446799
Abstract
Background: The prevalence of gingival overgrowth in renal transplant recipients maintained on cyclosporine
A remains as essential and still unexplained problem for the patient, physician and periodontist.
Clinically significant gingival overgrowth may be associated with inflammation, pain, tooth migration, mastication and cosmetic disorders and it may cause physiological and psychological morbidity. Tacrolimus is a new immunosuppressant, a therapeutic alternative to CsA and has no adverse effect on the gingival tissues.
Case Report: We reported on a case of five patients after renal transplantation with severe CsA – induced
gingival overgrowth and different treatment modalities. Two of them underwent periodontal
therapy and surgical treatment - gingivectomy. The next three patients were converted from CsA to tacrolimus. Hygiene instructions to all patients were given. After 2 years in surgery treated patients gingival overgrowth, degree and inflammation level were lower but still present. In patients converted to tacrolimus treatment almost complete regression of the gingival overgrowth without surgical intervention were observed.
Conclusions: Both periodontist and patient have an important role to play in improving oral hygiene and
gingival health. Cyclosporine-induced gingival overgrowth is effectively ameliorated by conversion
from CsA to tacrolimus while surgical intervention provides only temporary remedy.
Keywords: Cyclosporine A, Gingival Overgrowth, Tacrolimus, periodontal treatment, Gingivectomy
48
In Press
12 Feb 2024 : Case report
Erdheim-Chester Disease Occult on Radiographs and CT but Visible on MRI and PETAm J Case Rep In Press; DOI: 10.12659/AJCR.941169
12 Feb 2024 : Case report
Surgical Treatment of Spontaneous Superficial Temporal Artery Arteriovenous Malformation: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.942839
13 Feb 2024 : Case report
Warfarin Woes: A Rare Case of Hemoperitoneum with Intramural Small Bowel HematomaAm J Case Rep In Press; DOI: 10.12659/AJCR.943519
13 Feb 2024 : Case report
Hemorrhagic Presentation in Primary Central Nervous System Lymphoma: A Case StudyAm J Case Rep In Press; DOI: 10.12659/AJCR.942951
Most Viewed Current Articles
07 Mar 2024 : Case report
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
23 Feb 2022 : Case report
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250